Inventor · disambiguated record
Joaquina Faour
Also filed as: FAOUR JOAQUINA
38 granted patents·11 pending applications·1,621 citations·filing 1998–2021
98Inventor score
Files withOSMOTICA CORP20OSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG7OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT5VERGEZ JUAN A3ADAMAS PHARMACEUTICALS INC2
Top patents by PatentIndex Score
49 records- 0198US6753011B2Combined diffusion/osmotic pumping drug delivery systemOSMOTICA CORP·Filed 2002·Granted Jun 22, 2004·127 cites·30 claims
- 0298US6599284B2Osmotic device having a preformed passageway that increases in sizeOSMOTICA CORP·Filed 2000·Granted Jul 29, 2003·175 cites·62 claims
- 0398US6352721B1Combined diffusion/osmotic pumping drug delivery systemOSMOTICA CORP·Filed 2000·Granted Mar 5, 2002·213 cites·37 claims
- 0497US6491949B2Osmotic device within an osmotic deviceOSMOTICA CORP·Filed 2001·Granted Dec 10, 2002·204 cites·55 claims
- 0595US6572890B2Osmotic device containing venlafaxine and an anti-psychotic agentOSMOTICA CORP·Filed 2000·Granted Jun 3, 2003·62 cites·23 claims
- 0695US6569456B2Osmotic device containing diltiazem and an ACE inhibitor or diureticOSMOTICA CORP·Filed 2001·Granted May 27, 2003·72 cites·59 claims
- 0794US10213394B1Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG·Filed 2018·Granted Feb 26, 2019·7 cites·28 claims
- 0894US8574626B2Osmotic device containing amantadine and an osmotic saltVERGEZ JUAN A·Filed 2012·Granted Nov 5, 2013·36 cites·72 claims
- 0994US6605302B2Drug delivery device containing oseltamivir and an H1 antagonistOSMOTICA CORP·Filed 2001·Granted Aug 12, 2003·47 cites·38 claims
- 1094US6004582AMulti-layered osmotic devicePHOENIX U S A INC LAB·Filed 1998·Granted Dec 21, 1999·271 cites·23 claims
- 1193US8637080B2Rupturing controlled release device comprising a subcoatPASTINI ANA C·Filed 2008·Granted Jan 28, 2014·35 cites·43 claims
- 1293US6613357B2Osmotic device containing pseudoephedrine and an H1 antagonistOSMOTICA CORP·Filed 2000·Granted Sep 2, 2003·48 cites·37 claims
- 1392US6599532B2Osmotic device containing alprazolam and an antipsychotic agentOSMOTICA CORP·Filed 2001·Granted Jul 29, 2003·39 cites·29 claims
- 1491US8252331B2Osmotic device containing amantadine and an osmotic saltMEYER GLENN A·Filed 2005·Granted Aug 28, 2012·30 cites·20 claims
- 1591US6248359B1Multi-tablet oxybutynin system for treating incontinencePHOENIX U S A INC LAB·Filed 2000·Granted Jun 19, 2001·40 cites·31 claims
- 1690US10213393B1Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOESSEGU TARSASAG·Filed 2018·Granted Feb 26, 2019·7 cites·26 claims
- 1790US8029822B2Rupturing controlled release device having a preformed passagewayOSMOTICA KERESKEDELMI ES SEOLGALTATO KFT·Filed 2004·Granted Oct 4, 2011·44 cites·60 claims
- 1889US10500171B2Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG·Filed 2019·Granted Dec 10, 2019·2 cites·23 claims
- 1989US9855258B1Dose-dumping resistant controlled release dosage formOSMOTICA KERESKEDELMI ES SZOLGALTATO KFT·Filed 2017·Granted Jan 2, 2018·3 cites·30 claims
- 2089US6521255B2Osmotic device containing ranitidine and a prokinetic agentOSMOTICA CORP·Filed 2001·Granted Feb 18, 2003·28 cites·32 claims
- 2188US10512617B2Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG·Filed 2019·Granted Dec 24, 2019·2 cites·29 claims
- 2288US10500172B2Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG·Filed 2019·Granted Dec 10, 2019·2 cites·29 claims
- 2387US10265308B2Dose-dumping resistant controlled release dosage formOSMOTICA KERESKEDELMI ES SZOLGALTATO KFT·Filed 2017·Granted Apr 23, 2019·2 cites·18 claims
- 2486US9827234B1Dose-dumping resistant controlled release dosage formOSMOTICA KERESKEDELMI ES SZOLGALTATO KFT·Filed 2017·Granted Nov 28, 2017·2 cites·30 claims
- 2586US9707217B1Dose-dumping resistant controlled release dosage formOSMOTICA KERESKEDELMI ES SZOLGALTATO KFT·Filed 2017·Granted Jul 18, 2017·2 cites·29 claims
- 2686US7208176B2Drug delivery device containing neuraminidase inhibitor and an H1 antagonistOSMOTICA CORP·Filed 2003·Granted Apr 24, 2007·16 cites·50 claims
- 2786USRE39069EMulti-layered osmotic deviceOSMOTICA CORP·Filed 2001·Granted Apr 18, 2006·28 cites·54 claims
- 2885US6676933B2Pharmaceutical composition containing mosapride and pancreatinOSMOTICA CORP·Filed 2001·Granted Jan 13, 2004·21 cites·8 claims
- 2984US7008641B2Osmotic device containing venlafaxine and an anti-psychotic agentOSMOTICA CORP·Filed 2003·Granted Mar 7, 2006·13 cites·35 claims
- 3077US10500170B2Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG·Filed 2019·Granted Dec 10, 2019·1 cites·23 claims
- 3175US11890261B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2021·Granted Feb 6, 2024·0 cites·18 claims
- 3274US7147870B2Osmotic device containing pseudoephedrine and an H1 antagonistOSMOTICA CORP·Filed 2003·Granted Dec 12, 2006·4 cites·44 claims
- 3374US2020129454A1Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG·Filed 2019·Application pending·0 cites
- 3473US8293799B2Osmotic device containing a venlafaxine salt and a salt having an ion in commonFELEDER ETHEL C·Filed 2004·Granted Oct 23, 2012·8 cites·30 claims
- 3573US2020129455A1Composition and method for treating neurological diseaseMEYER GLENN A·Filed 2019·Application pending·0 cites
- 3671US7569794B2Laser drilling system and methodOSMOTICA CORP·Filed 2004·Granted Aug 4, 2009·19 cites·26 claims
- 3767US2008175909A1Delivery device containing venlafaxine and memantine and method of use thereofOSMOTICA CORP·Filed 2007·Application pending·0 cites
- 3865US10695336B2Dose-dumping resistant controlled release dosage formOSMOTICA KERESKEDELMI ES SZOLGALTATO KFT·Filed 2019·Granted Jun 30, 2020·0 cites·23 claims
- 3964US11833121B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2020·Granted Dec 5, 2023·0 cites·16 claims
- 4063US6458808B1Pharmaceutical composition for the treatment of cognitive cerebrovascular diseaseOSMOTICA CORP·Filed 2001·Granted Oct 1, 2002·1 cites·19 claims
- 4160US6809288B2Laser drilling system and methodOSMOTICA CORP·Filed 2002·Granted Oct 26, 2004·10 cites·37 claims
- 4259US2008050335A1Ophthalmic SolutionsOSMOTICA CORP·Filed 2007·Application pending·0 cites
- 4354US2007275060A1Extended release solid pharmaceutical composition containing carbidopa and levodopaOSMOTICA COSTA RICA SA·Filed 2006·Application pending·0 cites
- 4454US2006177507A1Controlled release device containing lercanidipineFAOUR JOAQUINA·Filed 2006·Application pending·0 cites
- 4552US2019247331A1Composition and method for treating neurological diseaseOSMOTICA KERESKEDELMI ES SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG·Filed 2019·Application pending·0 cites
- 4650US2006063810A1Combination treatment for impaired motor function in parkinson's diseaseVERGEZ JUAN A·Filed 2005·Application pending·0 cites
- 4749US2006062851A1Delivery device containing venlafaxine and memantine and methods of use thereofVERGEZ JUAN A·Filed 2005·Application pending·0 cites
- 4845US2005129764A1Osmotic device containing licofeloneFiled 2003·Application pending·0 cites
- 4940US2004204413A1Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxantFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joaquina Faour files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →